Archimedes Tech SPAC Partners II Co. ATII

Financials SIC 6770 - Blank Checks Nasdaq

We are a blank check company incorporated in the Cayman Islands as an exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. We have neither engaged in any operations nor generated any revenue to date. Based on our business activities, the Company is a "shell company" as defined under the Securities Exchange Act of 1934, as amended (the "Exchange Act") because we have no operations and nominal assets consisting almost entirely of cash.

In June 2024, we issued to the sponsor an aggregate of 5,750,000 ordinary shares (the "founder shares") for an aggregate purchase price of $25,000, or approximately $0.004 per share. Prior to our sponsor's initial investment of $25,000, the Company had no assets, tangible or intangible.

Last close 10.65 2026-09-04
Market cap $315.1M 2026-06-30 share count
52-week range 10.19 - 11.40

Valuation FY2025 figures against the last close

P/S
P/E
P/FCF
EV/EBITDA
Dividend yield
Diluted EPS

Annual financial statements

Income statement

Fiscal year FY2025FY2024
SG&A $786.0K
Operating income -$786.0K
Net income $8.0M

Balance sheet

Fiscal year FY2025FY2024
Cash and equivalents $1.4M$0
Total current assets $1.5M$0
Total assets $241.3M$429.7K
Total current liabilities $137.5K$483.4K
Total liabilities $8.2M$483.4K
Retained earnings -$6.7M-$78.7K
Total equity -$6.7M$0

Cash flow

Fiscal year FY2025FY2024
Operating cash flow -$739.0K
Investing cash flow -$231.2M
Financing cash flow $233.3M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001437749-26-006780.

Others in SIC 6770

TickerCompanyMarket capP/ERevenue growth
DMII Drugs Made In America Acquisition II Corp. $647.8M
IACO Idea Acquisition Corp. $437.1M
KRAQ KRAKacquisition Corp $431.6M
TACO Berto Acquisition Corp. $393.6M 36.2x
ALDF Aldel Financial II Inc. $322.7M
FGII FG Imperii Acquisition Corp. $289.7M
SOUL Soulpower Acquisition Corp. $268.0M
DMAA Drugs Made In America Acquisition Corp. $261.2M